|
Report Date : |
31.12.2013 |
IDENTIFICATION DETAILS
|
Name : |
LLOYD LABORATORIES, INC. |
|
|
|
|
Registered Office : |
Brgy. Laging Handa, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
15.04.1993 |
|
|
|
|
Com. Reg. No.: |
AS093-02833 |
|
|
|
|
Legal Form : |
Not Available |
|
|
|
|
Line of Business : |
Manufacture,
import, buy & sell, wholesale, chemical, pharmaceutical and other manufacturer products. |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Exist |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2013
|
Country Name |
Previous Rating (30.06.2013) |
Current Rating (30.09.2013) |
|
Philippines |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
PHILIPPINES - ECONOMIC OVERVIEW
Philippine GDP growth, which cooled from 7.6% in 2010 to 3.9% in 2011, expanded to 6.6% in 2012 - meeting the government's targeted 6%-7% growth range. The 2012 expansion partly reflected a rebound from depressed 2011 export and public sector spending levels. The economy has weathered global economic and financial downturns better than its regional peers due to minimal exposure to troubled international securities, lower dependence on exports, relatively resilient domestic consumption, large remittances from four- to five-million overseas Filipino workers, and a rapidly expanding business process outsourcing industry. The current account balance had recorded consecutive surpluses since 2003; international reserves are at record highs; the banking system is stable; and the stock market was Asia's second best-performer in 2012. Efforts to improve tax administration and expenditure management have helped ease the Philippines' tight fiscal situation and reduce high debt levels. The Philippines received several credit rating upgrades on its sovereign debt in 2012, and has had little difficulty tapping domestic and international markets to finance its deficits. Achieving a higher growth path nevertheless remains a pressing challenge. Economic growth in the Philippines averaged 4.5% during the MACAPAGAL-ARROYO administration but poverty worsened during her term. Growth has accelerated under the AQUINO government, but with limited progress thus far in bringing down unemployment, which hovers around 7%, and improving the quality of jobs. Underemployment is nearly 20% and more than 40% of the employed are estimated to be working in the informal sector. The AQUINO administration has been working to boost the budgets for education, health, cash transfers to the poor, and other social spending programs, and is relying on the private sector to help fund major infrastructure projects under its Public-Private Partnership program. Long term challenges include reforming governance and the judicial system, building infrastructure, improving regulatory predictability, and the ease of doing business, attracting higher levels of local and foreign investments. The Philippine Constitution and the other laws continue to restrict foreign ownership in important activities/sectors (such as land ownership and public utilities)
|
Source
: CIA |
LLOYD
LABORATORIES, INC.
Company:
LLOYD LABORATORIES,
INC.
Address: Brgy. Laging Handa, Quezon City
Country: Philippines
Service Type: Normal
We conducted research and verification on LLOYD LABORATORIES, INC. Hereunder
our report, viz:
VERIFICATION WITH SECURITIES & EXCHANGE COMMISSION (SEC): LLOYD LABORATORIES, INC.
Certificate No.
: AS093-02833
Date
: April 15, 1993
Term
: Fifty (50) years
Address : 10th Lloyd Ave., FIBC, Tikay,
Malolos, Bulacan
Telephone No. : (632) 411 5860
-
-
(Per
GIS dtd. July 3, 2013)
-
Authorized
Capital Stock
- P70,000,000.
-
Amount
Subscribed
- P50,000,000.
-
Amount
Paid Up - P50,000,000.
-
Par
Value Per Share -
P 1.
-
No.
of Shares -
70,000,000
Primary
Purpose -
To manufacture, import, buy & sell, wholesale, chemical, pharmaceutical
and other manufacturer products.
|
Name/Nationality/Designation |
Paid – Up (As of Year 2013) |
|
Maximo P.
Balajadia – Filipino
President |
P21,462,500. |
|
Zenaida D.
Balajadia – Filipino Chairperson |
P21,237,500. |
|
Dennis D.
Balajadia – Filipino Board of
Director |
P 2,500,000. |
|
Lloyd D.
Balajadia – Filipino Board
of Director |
P 2,500,000. |
|
Dick D.
Balajadia – Filipino Board
of Director |
P 2,500,000 |
|
Conchita
E. De Laza
Treasurer |
NIL |
|
Atty.
Servando Timbol, Jr.
Corp. Secretary |
NIL |
|
TOTAL |
P50,000,000.
Vvvvvvvvvvvv |
From a modest beginning in 1989, the company has become a major player in the the Pharmaceutical Manufacturing Industry and is considered a leading, professionally operated pharmaceutical company in the Philippines and India. The company manufactures Tablet, Injectables, Capsules, Ointments, Soft Gelatin Capsules and others. Also produces “Bite Block” an anti insect/ mosquito ointment. It has manufacturing facilities in Bulacan and Quezon City. Currently, maintain manufacturing facility at No. 73 Scout Fernandez, Tomas Morato, Diliman, Quezon City.
As gathered, subject is maker of Mc3. Fern-c, Fitrum, Arthio, slenda, liveraide, lesofat vitamin/medicine brands. Likewise, an affiliate of DRAGON EDGE GROUP of India.
Subject was included in the List of Drug Manufacturers with good valid Good Manufacturing Practices (GMP) for 2012.
SITE INSPECTION: 73 Scout Fernandez St., Tomas Morato,
Diliman, Quezon City
Said address is a private compound where the official residence of the Bajaladia’s & business address of subject, situated in a residential/commercial neighborhood. The compound is protected with high concrete cement perimeter fence with steel plate gate manned by private security guards. Business activity is not visible from the outside. No business signage is displayed. A reliable informant confirm that the address is Lloyd Laboratories business address.
disclosed that the site is the business address of subject and further informed that the laboratory produces “Bite Block” an anti insect/mosquito.
Email Address : marketing@lloydlab.com
Telephone nos. : (632) 411 5860 / 411 5884
(632) 376 2284 / 376 2185
Fax No. : (632) 376 2286
Financial Statement, not available with SEC.
Sometime in 2011, ”the Dept. of Labor & Employment (DOLE), Region 3, held a
9th World Day Against Child Labor celebration in Central Luzon……………. The Bulacan State University
(BSU) Medical Team and LLOYD LABORATORIES, INC. were also in the said event to conduct free
medical check up and hand out medicines.”
A USFDA Import Refusal Report No. 112-6836679-1/1/4 was issued against product code
No. 66SCA27 manufactured by subject firm. Please see attached.
Subject is one of the Respondents in a court suit filed by Drugmakers Laboratories, Inc. –
Petitioner; against Dominador Jose Y. Nazario and Nida Balajadia - Respondents, per CA-G.R. SP –
No. 42747 for Unfair Competition filed with MeTC, criminal case no. 300410 – SA, dated Oct. 9, 2006.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.00 |
|
|
1 |
Rs.102.17 |
|
Euro |
1 |
Rs.85.19 |
INFORMATION DETAILS
|
Report Prepared
by : |
NIS |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome
financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.